Dr. Manish R. Patel, DO

Dr. Patel practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Patel's NPI, 1740204957, was assigned on July 27, 2006. Dr. Patel graduated from Kirksville College of Osteopathic Medicine in 2001. Dr. Patel holds Minnesota license 48188.

Dr. Patel's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Patel's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Patel is also affiliated with M Health Fairview Southdale Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Patel to 3 more hospitals, 2 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Patel is board certified in medical oncology by the American Board of Internal Medicine. Dr. Patel is licensed in Minnesota.

Dmand AI lists immune deficiency disease among the conditions Dr. Patel treats.

CMS data shows 110 Medicare services from Dr. Patel across 3 procedure codes in 2024, for 80 Medicare patients. Medicare paid $7,991 for them.

CMS counts 80 Medicare patients who saw Dr. Patel in 2024. The largest group is 65 to 74, with 39 patients. 71% of them have high blood pressure, and 60% have cancer. 23% are also on Medicaid. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 70, with 43% women.

In 2024, Dr. Patel wrote 371 Medicare Part D claims for 50 patients. 71% of them were for generic drugs. CMS names the drug for 267 of them, across 14 drugs with 11 or more claims each, at $1,103,262 in total drug cost. In 2023, CMS named 236 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Patel for performance year 2024, reported as part of a group. Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Patel as offering telehealth.

Dmand AI links 53 papers to Dr. Patel, published from 2009 to 2025. 2017 was the busiest year, with 6. The most frequent topics are Lung Neoplasms, Cell Line, Tumor and Carcinoma, Non-Small-Cell Lung. Dr. Patel has published most often in Invest New Drugs. Dr. Patel's most frequent co-authors are Robert Arthur Kratzke, MD, Naomi Fujioka, MD and Shubham Pant, MD.

Dmand AI links Dr. Patel to 2 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Salivary Gland Neoplasms and Carcinoma, Bronchogenic.

CMS Open Payments shows 116 general payments to Dr. Patel from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 77% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $10,664. It also lists 17 research payments totaling $8,257 from 2020 to 2021.

Dmand AI lists 1 award for Dr. Patel, most recently CMS Stage 1 EHR in 2013.

Dr. Patel graduated from Kirksville College of Osteopathic Medicine in 2001.

Dr. Patel is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.